Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160509 (US10280160, Example 1. | US9682969, 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160545 (US10280160, Example 30. | US9682969, 30) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160511 (US10280160, Example 3. | US9682969, 3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160512 (US10280160, Example 6. | US9682969, 4 | US9682969,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160513 (US10280160, Example 5. | US9682969, 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160512 (US10280160, Example 6. | US9682969, 4 | US9682969,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160515 (US10280160, Example 9. | US9682969, 7 | US9682969,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160516 (US10280160, Example 8. | US9682969, 8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160515 (US10280160, Example 9. | US9682969, 7 | US9682969,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160518 (US10280160, Example 10. | US9682969, 10) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160519 (US10280160, Example 11. | US9682969, 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160520 (US10280160, Example 12. | US9682969, 12) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160521 (US10280160, Example 13. | US9682969, 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160522 (US10280160, Example 14. | US9682969, 14) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160523 (US10280160, Example 15. | US9682969, 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160525 (US10280160, Example 22. | US9682969, 17 | US968296...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160527 (US10280160, Example 19. | US9682969, 19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160529 (US10280160, Example 21. | US9682969, 21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160531 (US10280160, Example 24. | US9682969, 23 | US968296...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160528 (US10280160, Example 25. | US9682969, 20 | US968296...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160535 (US10280160, Example 27. | US9682969, 27) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160537 (US10280160, Example 29. | US9682969, 29) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160546 (US10280160, Example 31. | US9682969, 31) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160524 (US10280160, Example 16. | US9682969, 16) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160526 (US10280160, Example 18. | US9682969, 18) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160528 (US10280160, Example 25. | US9682969, 20 | US968296...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160525 (US10280160, Example 22. | US9682969, 17 | US968296...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160531 (US10280160, Example 24. | US9682969, 23 | US968296...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160534 (US10280160, Example 26. | US9682969, 26) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160536 (US10280160, Example 28. | US9682969, 28) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cystic fibrosis transmembrane conductance regulator [1-507,509-1480] (Homo sapiens (Human)) | BDBM160510 (US10280160, Example 2. | US9682969, 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Flatley Discovery Lab, LLC US Patent | Assay Description This protocol is designed to selectively screen small molecule compounds for F508del CFTR corrector activities in the YFP (yellow fluorescent protein... | US Patent US9682969 (2017) BindingDB Entry DOI: 10.7270/Q2SQ8XKT | |||||||||||
More data for this Ligand-Target Pair |